Efficacy and safety of Anakinra in idiopathic recurrent pericarditis: Results from the UPACITER studyMartin Michaud, G. Pugnet, L. Sailler et al.|International Journal of Cardiology|2025Cited by 11
Efficacy and Safety of Erythropoietic-Stimulating Agents with Ruxolitinib in Myelofibrosis Patients : A Retrospective Analysis on 45 Patients. on Behalf of the French Intergroup of Myeloproliferative Disorders (FIM)Sandra Malak, Lydia Roy, Françoise Boyer et al.|Blood|2016Cited by 3
Myelofibrosis in Real Life: Findings from the French Intergroup of Myeloproliferative Neoplasms (FIM) RegistryBrigitte Dupriez, Jean‐Jacques Kiladjian, Sylvie Chevret et al.|Blood|2016Cited by 1
A molecular signature predicts hematologic evolution in polycythemia vera patientsOlivier Mansier, Éric Lippert, Lina Benajiba et al.|Leukemia|2025Cited by 1